Shamburg News · 8-K filed Nov 16, 2026, 6:58 AM EST

Vycor Medical Reports Q3 2026 Revenue of $414,895, Down 19%, Net Loss Per Share $(0.00)

VYCO · VYCOR MEDICAL INC

  • Earnings
  • Financial statements
  • Materiality: high

Vycor Medical, Inc. reported revenue of $414,895 for the three months ended September 30, 2026, a decrease of 19% from the prior-year period, and revenue of $1,291,699 for the nine months, a decrease of 11%. The company reported a GAAP net loss available to common stockholders of $(161,447), or $(0.00) per share, for the quarter, and non-GAAP operating profit of $43,011 compared with $60,162 a year earlier. The results were released in a press release dated November 13, 2026, furnished as Exhibit 99.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001493152-26-051991.

Written from the filing by Shamburg Markets. Figures are as reported by the company.